STOCK TITAN

PetVivo Holdings Inc - PETVW STOCK NEWS

Welcome to our dedicated news page for PetVivo Holdings (Ticker: PETVW), a resource for investors and traders seeking the latest updates and insights on PetVivo Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PetVivo Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PetVivo Holdings's position in the market.

Rhea-AI Summary
PetVivo Holdings, Inc. is approaching a milestone of selling its signature product to its 500th veterinary clinic. The company has supplied the product to over 450 clinics in 47 states, reflecting its increasing presence across the country.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.39%
Tags
none
-
Rhea-AI Summary
PetVivo Holdings, Inc. has rescheduled its earnings conference call for the year ending March 31, 2023 due to a technical glitch. The call will now be held on June 30, 2023 at 10:00 AM ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.23%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.8%
Tags
Rhea-AI Summary
PetVivo Holdings, Inc. announces Dr. Jeremy Caplin as new Research Director
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.95%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
none
-
Rhea-AI Summary
PetVivo Holdings receives initial regulatory assessment for its Biomatrix Particulate Technology, paving the way for regulatory approval of various indications for human products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.52%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.44%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.75%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.07%
Tags
conferences
PetVivo Holdings Inc

Nasdaq:PETVW

PETVW Rankings

PETVW Stock Data

11.85M
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Minneapolis

About PETVW

petvivo, inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. petvivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. petvivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. petvivo, inc, gel-del technologies, inc. and cosmetalife a corporation are all wholly-owned subsidiaries of petvivo holdings, inc.